ReP USP - Resultado da busca

Filtros : "Dumitriu, Bogdan" Removido: "2013" Limpar

Filtros

Colaboração institucional
Afiliação dos autores externos normalizada
- university of michigan (um) (~1)
Afiliação dos autores externos não normalizada
- antônio ermírio de moraes cancer center, hospital são josé and beneficência portuguesa, são paulo (1)
- cardiopulmonary branch, bethesda (1)
- hematology branch, bethesda (1)
- johns hopkins university of medicine, baltimore, maryland, usa (1)
- national cancer institute, bethesda, maryland, usa (1)

Artigo de periodico
Danazol treatment for telomere diseases (2016)
Townsley, Danielle M.; Dumitriu, Bogdan; Liu, Delong; Biancotto, Angélique; Weinstein, Barbara; Chen, Christina; Hardy, Nathan; Mihalek, Andrew D.; Lingala, Shilpa; Kim, Yun Ju; Yao, Jianhua; Jones, Elizabeth; Gochuico, Bernadette R.; Heller, Theo; Wu, Colin O.; Calado, Rodrigo Tocantins; Scheinberg, Phillip; Young, Neal S.
Fonte: New England Journal of Medicine. Unidade: FMRP
Assuntos: DOENÇAS DA MEDULA ÓSSEA, CIRROSE HEPÁTICA, FIBROSE PULMONAR, ESTRÓGENOS, TELÔMERO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOWNSLEY, Danielle M. et al. Danazol treatment for telomere diseases. New England Journal of Medicine, v. 374, n. 20, p. 1922-1931, 2016Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa1515319. Acesso em: 03 nov. 2024.
APA
Townsley, D. M., Dumitriu, B., Liu, D., Biancotto, A., Weinstein, B., Chen, C., et al. (2016). Danazol treatment for telomere diseases. New England Journal of Medicine, 374( 20), 1922-1931. doi:10.1056/NEJMoa1515319
NLM
Townsley DM, Dumitriu B, Liu D, Biancotto A, Weinstein B, Chen C, Hardy N, Mihalek AD, Lingala S, Kim YJ, Yao J, Jones E, Gochuico BR, Heller T, Wu CO, Calado RT, Scheinberg P, Young NS. Danazol treatment for telomere diseases [Internet]. New England Journal of Medicine. 2016 ; 374( 20): 1922-1931.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1056/NEJMoa1515319
Vancouver
Townsley DM, Dumitriu B, Liu D, Biancotto A, Weinstein B, Chen C, Hardy N, Mihalek AD, Lingala S, Kim YJ, Yao J, Jones E, Gochuico BR, Heller T, Wu CO, Calado RT, Scheinberg P, Young NS. Danazol treatment for telomere diseases [Internet]. New England Journal of Medicine. 2016 ; 374( 20): 1922-1931.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1056/NEJMoa1515319
Artigo de periodico
Telomerase variant A279T induces telomere dysfunction and inhibits non-canonical telomerase activity in esophageal carcinomas (2014)
Zhang, Yuwei; Calado, Rodrigo do Tocantins; Rao, Makadev; Hong, Julie A.; Meeker, Alan K.; Dumitriu, Bogdan; Atay, Scott; McCormick, Peter J.; Garfield, Susan H.; Wangsa, Danny; Padilla-Nash, Hesed M.; Burkett, Sandra; Zhang, Mary; Kunst, Tricia F.; Peterson, Nathan R.; Xi, Sichuan; Inchauste, Suzanne; Altorki, Nasser K.; Casson, Alan G.; Beer, David G.; Harris, Curtis C.; Ried, Thomas; Young, Neal S.; Schrump, David S.
Fonte: PLOS ONE. Unidade: FMRP
Assuntos: CARCINOMA (GENÉTICA), NEOPLASIAS GÁSTRICAS (GENÉTICA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZHANG, Yuwei et al. Telomerase variant A279T induces telomere dysfunction and inhibits non-canonical telomerase activity in esophageal carcinomas. PLOS ONE, v. 9, n. 7, p. e101010-1 - e101010-15, 2014Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0101010. Acesso em: 03 nov. 2024.
APA
Zhang, Y., Calado, R. do T., Rao, M., Hong, J. A., Meeker, A. K., Dumitriu, B., et al. (2014). Telomerase variant A279T induces telomere dysfunction and inhibits non-canonical telomerase activity in esophageal carcinomas. PLOS ONE, 9( 7), e101010-1 - e101010-15. doi:10.1371/journal.pone.0101010
NLM
Zhang Y, Calado R do T, Rao M, Hong JA, Meeker AK, Dumitriu B, Atay S, McCormick PJ, Garfield SH, Wangsa D, Padilla-Nash HM, Burkett S, Zhang M, Kunst TF, Peterson NR, Xi S, Inchauste S, Altorki NK, Casson AG, Beer DG, Harris CC, Ried T, Young NS, Schrump DS. Telomerase variant A279T induces telomere dysfunction and inhibits non-canonical telomerase activity in esophageal carcinomas [Internet]. PLOS ONE. 2014 ; 9( 7): e101010-1 - e101010-15.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1371/journal.pone.0101010
Vancouver
Zhang Y, Calado R do T, Rao M, Hong JA, Meeker AK, Dumitriu B, Atay S, McCormick PJ, Garfield SH, Wangsa D, Padilla-Nash HM, Burkett S, Zhang M, Kunst TF, Peterson NR, Xi S, Inchauste S, Altorki NK, Casson AG, Beer DG, Harris CC, Ried T, Young NS, Schrump DS. Telomerase variant A279T induces telomere dysfunction and inhibits non-canonical telomerase activity in esophageal carcinomas [Internet]. PLOS ONE. 2014 ; 9( 7): e101010-1 - e101010-15.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1371/journal.pone.0101010

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo 2012 - 2024